Cochrane · systematic review · CD012774

Fecal transplantation for treatment of inflammatory bowel disease

Imdad, A, Pandit, NG, Zaman, M, et al. · Cochrane Database of Systematic Reviews · 2023 · Cochrane Library

Gut2 versionsAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
20
current version
GRADE rated
13
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 7 · 35%Very low 10 · 50%Low 3 · 15%Moderate 0 · 0%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

Current version only

Fecal microbiota transplantation compared to control for induction of remission in ulcerative colitis

Population: people with active UC
CD012774.PUB3 (current) · 5 questions
OutcomeEffectEvidenceStatus / GRADE
Induction of clinical remission in UC at longest
Fecal microbiota transplantation vs control
RR 1.79 [1.13, 2.84]10 studies · 468 participantsLow
Downgraded: risk of bias, imprecision, inconsistency
Serious adverse events with use of FMT for induction of remission in UC (RR > 1 favors control)
Fecal microbiota transplantation vs control
RR 1.77 [0.88, 3.55]10 studies · 468 participantsVery low
Downgraded: risk of bias, imprecision
Any adverse events with use of FMT for induction of remission in UC (RR > 1 favors control)
Fecal microbiota transplantation vs control
RR 0.99 [0.85, 1.16]9 studies · 417 participantsLow
Downgraded: risk of bias, imprecision
Induction of endoscopic remission in UC at longest
Fecal microbiota transplantation vs control
RR 1.45 [0.64, 3.29]5 studies · 285 participantsLow
Downgraded: risk of bias, imprecision, inconsistency
Quality‐of‐life scores: IBDQ with use of FMT for induction of remission in UC (MD > 0 favors FMT)
Fecal microbiota transplantation vs control
no estimate extracted3 studies · 131 participantsVery low
Downgraded: risk of bias, imprecision, inconsistency

Fecal microbiota transplantation compared to control for maintenance of remission in ulcerative colitis

Population: people with UC in remission
CD012774.PUB3 (current) · 5 questions
OutcomeEffectEvidenceStatus / GRADE
Maintenance of clinical remission in UC (RR > 1 favors intervention)
Fecal microbiota transplantation vs control
RR 2.97 [0.26, 34.42]2 studies · 71 participantsVery low
Downgraded: risk of bias, imprecision, inconsistency
Serious adverse events with use of FMT for maintenance of remission in UC (RR > 1 favors control)
Fecal microbiota transplantation vs control
no estimate extracted2 studies · 71 participantsVery low
Downgraded: risk of bias, imprecision
Any adverse events with use of FMT for maintenance of remission in UC (RR > 1 favors the control)
Fecal microbiota transplantation vs control
RR 1.16 [0.85, 1.59]2 studies · 71 participantsVery low
Downgraded: risk of bias, imprecision
Maintenance of endoscopic remission in UC (RR > 1 favors FMT)
Fecal microbiota transplantation vs control
RR 3.28 [0.73, 14.74]2 studies · 71 participantsVery low
Downgraded: risk of bias, imprecision, inconsistency
Quality‐of‐life scores with use of FMT for maintenance of remission in UC
Fecal microbiota transplantation vs control
no estimate extracted1 study · 10 participantsVery low
Downgraded: risk of bias, imprecision

Fecal microbiota transplantation compared to control for induction of remission in Crohn disease

Population: people with active CD
CD012774.PUB3 (current) · 5 questions
OutcomeEffectEvidenceStatus / GRADE
Induction of clinical remission in CD
Fecal microbiota transplantation vs control
no estimate extracted0 studies · 0 participantsUngraded
Serious adverse events with use of FMT for induction of remission in CD
Fecal microbiota transplantation vs control
no estimate extracted0 studies · 0 participantsUngraded
Any adverse events with use of FMT for induction of remission in CD
Fecal microbiota transplantation vs control
no estimate extracted0 studies · 0 participantsUngraded
Induction of endoscopic remission in CD
Fecal microbiota transplantation vs control
no estimate extracted0 studies · 0 participantsUngraded
Quality‐of‐life scores with use of FMT for induction of remission in CD
Fecal microbiota transplantation vs control
no estimate extracted0 studies · 0 participantsUngraded

Fecal microbiota transplantation compared to control for maintenance of remission in Crohn disease

Population: people with CD in remission
CD012774.PUB3 (current) · 5 questions
OutcomeEffectEvidenceStatus / GRADE
Maintenance of remission in CD
Fecal microbiota transplantation vs control
RR 1.21 [0.36, 4.14]1 study · 21 participantsVery low
Downgraded: risk of bias, imprecision
Serious adverse events with use of FMT for maintenance of remission in CD
Fecal microbiota transplantation vs control
no estimate extracted1 study · 1 participantsVery low
Downgraded: risk of bias, imprecision
Any adverse events with use of FMT for maintenance of remission in CD
Fecal microbiota transplantation vs control
no estimate extracted1 study · 1 participantsVery low
Downgraded: risk of bias, imprecision
Maintenance of endoscopic remission in CD
Fecal microbiota transplantation vs control
no estimate extracted0 studies · 0 participantsUngraded
Quality‐of‐life scoreswith use of FMT for maintenance of remission in CD
Fecal microbiota transplantation vs control
no estimate extracted0 studies · 0 participantsUngraded

Fecal microbiota transplantation compared to control for treatment of ulcerative colitis

Population: Participants with active ulcerative colitis inadequately controlled with medication
CD012774.PUB2 · 7 questions
OutcomeEffectEvidenceStatus / GRADE
Clinical remission at 8 weeks
Fecal microbiota transplantation vs control
RR 2.03 [1.07, 3.86]4 studies · 277 participantsLow
Downgraded: inconsistency
Serious adverse events
Fecal microbiota transplantation vs control
RR 1.4 [0.55, 3.58]4 studies · 277 participantsLow
Downgraded: imprecision, inconsistency
Adverse events
Fecal microbiota transplantation vs control
RR 1.03 [0.81, 1.31]2 studies · 129 participantsModerate
Downgraded: imprecision, inconsistency
Clinical response at 8 weeks
Fecal microbiota transplantation vs control
RR 1.7 [0.98, 2.95]4 studies · 277 participantsLow
Downgraded: imprecision, inconsistency
Endoscopic remission at 8 weeks
Fecal microbiota transplantation vs control
RR 2.96 [1.6, 5.48]3 studies · 229 participantsModerate
Downgraded: imprecision, inconsistency
Clinical relapse at 12 weeks
Fecal microbiota transplantation vs control
RR 0.28 [0.02, 4.98]1 study · 17 participantsLow
Downgraded: imprecision, inconsistency
Endoscopic response at 8 weeks
Fecal microbiota transplantation vs control
RR 1.36 [0.26, 7.02]2 studies · 129 participantsVery low
Downgraded: imprecision, inconsistency